Upscale
VC Fund
London, United Kingdom
Upscale is a VC fund in London focused on Software and SaaS. Upscale helps the UK’s most promising tech companies to accelerate their growth and unlock the key to scaling successfully.Based on the values of honesty, intimacy and trust, this established, curated programme is designed to reflect companies’ scaling journeys, exploring fundamental growth challenges, such as hiring, maintaining company cultureand international expansion.Companies on the Upscale programme will benefit from open conversations, peer-to-peer learning opportunities, meetups and workshops, delivered by expert scale coaches and seasoned entrepreneurs who have been through it all. It’s free to join, and they don’t take an equity stake in your business either.
- Total investments:
- 117
- Last investment:
- Lead investor:
- 2%
Last updated:
For AI agents: llms.txt
Industries Upscale invests in
Stages Upscale invests in
Countries Upscale invests in
Investment Focus
Industry
- Software 32 (27%)
- SaaS 20 (17%)
- Artificial Intelligence 17 (15%)
- Information Technology 15 (13%)
- E-Commerce 14 (12%)
Stage
- Venture - Series Unknown 83 (71%)
- Funding Round 16 (14%)
- Series A 6 (5%)
- Seed 4 (3%)
- Pre-Seed 2 (2%)
Country
- United Kingdom 100 (85%)
- United States 5 (4%)
- Estonia 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Vested Finance is an online investment platform developing an avenue for Indian investors. It provides a low cost and easy-to-use platform that includes knowledge and insights to help clients make smart investment decisions. The company's zero-commission online platform requires no minimum balance and allows investment in U.S. stocks inminutes. Investors can choose individual stocks or ETFs, or select from a variety of curated portfolios created with various goals, themes, and risk levels in mind | $12M / Series A / Apr 05, 2022 | |
|
|
Healthera operates a leading healthcare marketplace that provides patients with medicines, healthcare services and products through the largest digital platform of pharmacies and GPs in the UK, including national chains and independent providers. Our technology empowers patients to access faster medicine delivery and personalised medical carelocal to them. We reinvent the pharmacy’s operating model which leads to better patient communication, more cross-sales and stronger customer loyalty.We focus on digitising and automating primary care processes in order to improve prescribing efficiency and patient experience while reducing wastage for the NHS. In partnership with over 1000 pharmacies and CCGs across the UK, Healthera has a reach of over 20 million. Our technology is accredited by NHS Digital and we are one of the fastest-growing digital health companies in Europe.Headquartered in Cambridge, we’re an international team with 12 nationalities and a unified passion for increasing efficiency for healthcare with human-centric technology. We exist to transform the way a nation delivers its healthcare to its population, all the way from prescriptions to personalised clinical services. | Venture - Series Unknown / Mar 01, 2021 | |
|
|
Curu enables lenders to open more accounts by showing users the actions necessary to meet eligibility for their financial goals. Curu has become a fast-growing technology provider with its application’s sophisticated algorithms designed to boost consumer credit scores and its innovative “Extended Approval Plan” and customized risk model.Userslink all of their accounts to their secured Curu profile and Curu’s engine calculates ways to improve the end-users credit score in order to help them meet eligibility requirements and get approved for financial products such as credit cards, personal loans, auto loans, and mortgages. Financial institutions contract with Curu to provide their clientele with a solution consisting of an individualized behavioral modification and a credit score improval program that generates new accounts. | $3M / Seed / May 22, 2020 | |
|
|
Attest is a fast-scaling, SaaS business based in London and New York, and backed by investors including NEA, one of Silicon Valley's most prolific venture capital firms with over 225 portfolio company IPOs since 1977.Attest is a consumer research platform that delivers consumer data that drive predictable and repeatable growth to businesses.The Attest platform enables businesses to engage directly with >110 million consumers across >45 countries, starting in 90 seconds. Attest enables businesses to learn, measure, and grow ever-faster, across marketing, product, brand, innovation, competition, pricing, and beyond.Great companies put consumers and data at the heart of every decision. Attest makes this possible for anyone in any business, continuously, on a global scale. Clients use Attest to crack their greatest growth problems and fill the most valuable gaps in their knowledge, informing real decisions with fresh new inputs every day. | $16M / Series A / Apr 08, 2019 | |
|
|
The OvuSense™ fertility monitoring family is designed for every step in your journey to pregnancy. From getting pregnant to getting help, we're with you every step of the way. The OvuSense family provides everything you need in ovulation and cycle monitoring to improve your chances of getting pregnant.Designed for your complete fertilityjourney, the OvuSense family works seamlessly with the OvuSense App to upload your data and provide you fertility updates in real time. | $2.6M / Series A / Jan 25, 2019 | |
|
|
Sweatcoin is a digital currency backed by physical movement. They verify and convert movement into currency. Users can then donate it to charity, transfer to other users or spend on products, services, and experiences provided by Sweatcoin vendors and user community.Sweatcoin tackles Present Bias by moving the future benefits of exercise into thehere and now- immediately converting movement into a digital currency and changing the perception of physical movement. | Venture - Series Unknown / Jan 25, 2019 | |
|
|
Doctify is a high-growth HeathTech company revolutionizing the global healthcare market. Having expanded into 4 markets with an ambitious growth plan over the coming year. Doctify has developed a first-of-its-kind healthcare-specific patient feedback and review product allowing healthcare providers to drive improvements in patient care on a dailybasis. Our technology allows healthcare providers to collect and digitize patient feedback and publish it through multiple channels (both externally and internally). The SaaS tool provides insights and analytics into the care they provide. It means for the first time patients can read real-time verified feedback for a hospital, clinic, or doctor for a specific condition or procedure. | Venture - Series Unknown / Jan 25, 2019 | |
|
|
BookingLive provides powerful scheduling, reservation and purchasing experiences that create profitable customer relationships. BookingLive is the leading platform trusted by government departments, retailers, NHS trusts and large multinational organizations to manage their most important customer engagement journeys. These journeys aredata-driven, secure, and fully integrated with internal systems and software. BookingLive have worked with organizations like SKY, BBC, CAPITA, and the UK Government processing millions of bookings every single year. | Venture - Series Unknown / Jan 25, 2019 | |
|
|
Oxehealth secures world-first medical device certification for software enabling a digital video camera to remotely detect pulse and breathing rate, with the potential to transform care for elderly and vulnerable people in rooms where staff cannot always be present. Measure pulse rate and breathing rate totally contact free, be alerted to riskyactivities (for example a dementia patient getting out of bed) and review objective data on activity and vital signs to inform care planning.Oxehealth gives you more time for hands on care.We are the first company in the world to certify software as a medical device which enables a secure optical sensor to measure vital signs from right across a room. Our Digital Care Assistant is paying attention to every room when you can't be there. This Software as a Service solution generates the alerts and reports clinicians, carers and custodians need, seamlessly slotted into their existing workflow. The Digital Care Assistant is helping hundreds of staff in mental health, police, prison care home, acute hospital and home care settings. A spin out from Oxford University's Department of Engineering, Oxehealth’s technology can measure pulse & breathing rate and human activity & behaviour using proprietary algorithms which harness deep learning, computer vision and signal processing techniques.We are growing fast and always on the look out for talented team mates to join us across research, engineering, operations, sales and marketing. Take a look at www.oxehealth.com - we’d love to hear from you. | Venture - Series Unknown / Jan 25, 2019 | |
|
|
Futrli is on a quest to move the needle on the small business economy, which spans over 130 million small businesses globally. Founded in 2014, Futrli supports over 40,000 businesses and 1,000 accountants in 130 countries through their 100% cloud-based platform that helps small businesses make decisions and take actions that lead to success.Through a powerful suite of reporting, budgeting, cash flow forecasting and predictive modelling tools, SMEs can plan for the future, get a grip on cash flow and see how their business is performing in real time. For accountants working with SMEs, Futrli’s CPD-accredited Advisory Certification course helps them achieve their advisory potential. Futrli operates globally and has offices in Brighton (UK), Sydney and Melbourne (Australia). | Venture - Series Unknown / Jan 25, 2019 | |
| See all 117 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Upscale invest in?
Upscale invests primarily in Software, SaaS and Artificial Intelligence startups, most often at Venture - Series Unknown and Funding Round stage. Most of the 117 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Upscale last invest?
The most recent investment recorded for Upscale closed in Apr 2022. Shizune tracks 117 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!